Showing results (1571-1580 of 26,316) with videos related to
Sort By:
Pageof 2,632
Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Exploring selectivity requirements for COX-2 versus COX-1 binding of 3,4-diaryloxazolones using E-state indexKunal Roy, Santanu Chakraborty, Achintya SahaBioorganic & Medicinal Chemistry Letters|October 14, 2003
Synthesis and biological evaluation of GABA derivatives able to cross the blood-brain barrier in ratsVincenzo Carelli, Felice Liberatore, Luigi Scipione, et al.Bioorganic & Medicinal Chemistry Letters|October 14, 2003
New benzylidenethiazolidinediones as antibacterial agentsDirk A Heerding, Lisa T Christmann, Tammy J Clark, et al.Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Synthesis of a highly active new anti-HIV agent 2',3'-didehydro-3'-deoxy-4'-ethynylthymidineKazuhiro Haraguchi, Shingo Takeda, Hiromichi Tanaka, et al.Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Aryl piperazine melanocortin MC4 receptor agonistsBrian Dyck, Jessica Parker, Teresa Phillips, et al.Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Determination of binding affinities of triplex forming oligonucleotides using a fluorescent intercalator displacement (FID) assayBryan K S Yeung, Winston C Tse, Dale L BogerBioorganic & Medicinal Chemistry Letters|October 14, 2003
High-resolution assessment of protein DNA binding affinity and selectivity utilizing a fluorescent intercalator displacement (FID) assayYoung-Wan Ham, Winston C Tse, Dale L BogerBioorganic & Medicinal Chemistry Letters|October 14, 2003
Structure-activity relationship of triaryl propionic acid analogues on the human EP3 prostanoid receptorMichel Gallant, Michel Belley, Marie-Claude Carrière, et al.Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Structure elucidation of Sch 538415, a novel acyl carrier protein synthase inhibitor from a microorganismMin Chu, Ronald Mierzwa, Ling Xu, et al.Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: identification and optimisation of substituted 2,4-bis anilino pyrimidinesGloria A Breault, Rebecca P A Ellston, Stephen Green, et al.Pageof 2,632